Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 37

1.

Presymptomatic Screening for Intracranial Aneurysms in Patients with Autosomal Dominant Polycystic Kidney Disease.

Sanchis IM, Shukoor S, Irazabal MV, Madsen CD, Chebib FT, Hogan MC, El-Zoghby Z, Harris PC, Huston J, Brown RD, Torres VE.

Clin J Am Soc Nephrol. 2019 Aug 7;14(8):1151-1160. doi: 10.2215/CJN.14691218. Epub 2019 Jul 30.

PMID:
31362991
2.

Bacterial Cholangitis in Autosomal Dominant Polycystic Kidney and Liver Disease.

Martin WP, Vaughan LE, Yoshida K, Takahashi N, Edwards ME, Metzger A, Senum SR, Masyuk TV, LaRusso NF, Griffin MD, El-Zoghby Z, Harris PC, Kremers WK, Nagorney DM, Kamath PS, Torres VE, Hogan MC.

Mayo Clin Proc Innov Qual Outcomes. 2019 May 27;3(2):149-159. doi: 10.1016/j.mayocpiqo.2019.03.004. eCollection 2019 Jun.

3.

Long-Term Administration of Tolvaptan in Autosomal Dominant Polycystic Kidney Disease.

Edwards ME, Chebib FT, Irazabal MV, Ofstie TG, Bungum LA, Metzger AJ, Senum SR, Hogan MC, El-Zoghby ZM, Kline TL, Harris PC, Czerwiec FS, Torres VE.

Clin J Am Soc Nephrol. 2018 Aug 7;13(8):1153-1161. doi: 10.2215/CJN.01520218. Epub 2018 Jul 19. Erratum in: Clin J Am Soc Nephrol. 2019 Jun 7;14(6):910.

4.

Cystatin C Predicts Renal Recovery Earlier Than Creatinine Among Patients With Acute Kidney Injury.

Gharaibeh KA, Hamadah AM, El-Zoghby ZM, Lieske JC, Larson TS, Leung N.

Kidney Int Rep. 2017 Nov 3;3(2):337-342. doi: 10.1016/j.ekir.2017.10.012. eCollection 2018 Mar.

5.

Younger Adults Initiating Hemodialysis: Antidepressant Use for Depression Associated With Higher Health Care Utilization.

Vork DL, Schneekloth TD, Bartley AC, Vaughan LE, Lapid MI, Jowsey-Gregoire SG, El-Zoghby ZM, Herrmann SM, Tran CL, Albright RC, Hickson LJ.

Mayo Clin Proc. 2018 Mar;93(3):321-332. doi: 10.1016/j.mayocp.2017.12.008.

6.

Autosomal Dominant Polycystic Kidney Patients May Be Predisposed to Various Cardiomyopathies.

Chebib FT, Hogan MC, El-Zoghby ZM, Irazabal MV, Senum SR, Heyer CM, Madsen CD, Cornec-Le Gall E, Behfar A, Harris PC, Torres VE.

Kidney Int Rep. 2017 Jun 6;2(5):913-923. doi: 10.1016/j.ekir.2017.05.014. eCollection 2017 Sep.

7.

The Rate of Acute Kidney Injury After Total Hip Arthroplasty Is Low but Increases Significantly in Patients with Specific Comorbidities.

Gharaibeh KA, Hamadah AM, Sierra RJ, Leung N, Kremers WK, El-Zoghby ZM.

J Bone Joint Surg Am. 2017 Nov 1;99(21):1819-1826. doi: 10.2106/JBJS.16.01027.

PMID:
29088036
8.

An Unusual Case of Acute Myeloid Leukemia Cell Infiltration of the Renal Allograft: A Case Report and Review of Literature.

Manohar S, Sathick IJ, Grande J, El-Zoghby Z, Leung N.

Transplant Proc. 2017 Sep;49(7):1578-1582. doi: 10.1016/j.transproceed.2017.04.006. Review.

PMID:
28838444
9.

Renal Outcomes in Patients With IgA Nephropathy Undergoing Liver Transplant: A Retrospective Cohort Study.

Hommos MS, El-Zoghby ZM.

Transplant Direct. 2017 Jul 11;3(8):e193. doi: 10.1097/TXD.0000000000000708. eCollection 2017 Aug.

10.

Soluble ST2 does not change cardiovascular risk prediction compared to cardiac troponin T in kidney transplant candidates.

Keddis MT, El-Zoghby Z, Kaplan B, Meeusen JW, Donato LJ, Cosio FG, Steidley DE.

PLoS One. 2017 Jul 13;12(7):e0181123. doi: 10.1371/journal.pone.0181123. eCollection 2017.

11.

Charcoal hemoperfusion in the treatment of medically refractory pruritus in cholestatic liver disease.

Kittanamongkolchai W, El-Zoghby ZM, Eileen Hay J, Wiesner RH, Kamath PS, LaRusso NF, Watt KD, Cramer CH, Leung N.

Hepatol Int. 2017 Jul;11(4):384-389. doi: 10.1007/s12072-016-9775-9. Epub 2016 Dec 8.

PMID:
27933591
12.

Calciphylaxis: A Disease of Pannicular Thrombosis.

El-Azhary RA, Patzelt MT, McBane RD, Weaver AL, Albright RC, Bridges AD, Claus PL, Davis MD, Dillon JJ, El-Zoghby ZM, Hickson LJ, Kumar R, McCarthy-Fruin KA, McEvoy MT, Pittelkow MR, Wetter DA, Williams AW, McCarthy JT.

Mayo Clin Proc. 2016 Oct;91(10):1395-1402. doi: 10.1016/j.mayocp.2016.06.026.

PMID:
27712638
13.

Survival, Risk Factors, and Effect of Treatment in 101 Patients With Calciphylaxis.

McCarthy JT, El-Azhary RA, Patzelt MT, Weaver AL, Albright RC, Bridges AD, Claus PL, Davis MD, Dillon JJ, El-Zoghby ZM, Hickson LJ, Kumar R, McBane RD, McCarthy-Fruin KA, McEvoy MT, Pittelkow MR, Wetter DA, Williams AW.

Mayo Clin Proc. 2016 Oct;91(10):1384-1394. doi: 10.1016/j.mayocp.2016.06.025.

PMID:
27712637
14.

Native Nephrectomy in Renal Transplant Recipients with Autosomal Dominant Polycystic Kidney Disease.

Chebib FT, Prieto M, Jung Y, Irazabal MV, Kremers WK, Dean PG, Rea DJ, Cosio FG, Torres VE, El-Zoghby ZM.

Transplant Direct. 2015 Nov 1;1(10):e43. Epub 2015 Nov 18.

15.

Effect of genotype on the severity and volume progression of polycystic liver disease in autosomal dominant polycystic kidney disease.

Chebib FT, Jung Y, Heyer CM, Irazabal MV, Hogan MC, Harris PC, Torres VE, El-Zoghby ZM.

Nephrol Dial Transplant. 2016 Jun;31(6):952-60. doi: 10.1093/ndt/gfw008. Epub 2016 Feb 29.

16.

Extracorporeal Elimination of Piperacillin/Tazobactam during Molecular Adsorbent Recirculating System Therapy.

Personett HA, Larson SL, Frazee EN, Nyberg SL, El-Zoghby ZM.

Pharmacotherapy. 2015 Aug;35(8):e136-9. doi: 10.1002/phar.1618.

PMID:
26289310
17.

Volume regression of native polycystic kidneys after renal transplantation.

Jung Y, Irazabal MV, Chebib FT, Harris PC, Dean PG, Prieto M, Cosio FG, El-Zoghby ZM, Torres VE.

Nephrol Dial Transplant. 2016 Jan;31(1):73-9. doi: 10.1093/ndt/gfv227. Epub 2015 Jun 4.

18.

Impact of molecular adsorbent recirculating system therapy on tacrolimus elimination: a case report.

Personett HA, Larson SL, Frazee EN, Nyberg SL, Leung N, El-Zoghby ZM.

Transplant Proc. 2014 Sep;46(7):2440-2. doi: 10.1016/j.transproceed.2014.02.013. Epub 2014 Jul 10.

PMID:
25017243
19.

Kidney allograft function and histology in recipients dying with a functioning graft.

Lorenz EC, El-Zoghby ZM, Amer H, Dean PG, Hathcock MA, Kremers WK, Stegall MD, Cosio FG.

Am J Transplant. 2014 Jul;14(7):1612-8. doi: 10.1111/ajt.12732. Epub 2014 Jun 6.

20.

Imaging classification of autosomal dominant polycystic kidney disease: a simple model for selecting patients for clinical trials.

Irazabal MV, Rangel LJ, Bergstralh EJ, Osborn SL, Harmon AJ, Sundsbak JL, Bae KT, Chapman AB, Grantham JJ, Mrug M, Hogan MC, El-Zoghby ZM, Harris PC, Erickson BJ, King BF, Torres VE; CRISP Investigators.

J Am Soc Nephrol. 2015 Jan;26(1):160-72. doi: 10.1681/ASN.2013101138. Epub 2014 Jun 5.

21.

Cardiovascular disease burden and risk factors before and after kidney transplant.

Keddis MT, Bhutani G, El-Zoghby ZM.

Cardiovasc Hematol Disord Drug Targets. 2014;14(3):185-94. Review.

PMID:
24720457
22.

Treatment of persistent/medically refractory covert hepatic encephalopathy with the molecular adsorbent recirculating system.

Leise MD, Leung N, El-Zoghby Z, Gonzalez Gonzalez HC, Cerhan JH, Nyberg SL.

Liver Transpl. 2014 Jul;20(7):867-8. doi: 10.1002/lt.23883. Epub 2014 May 26. No abstract available.

23.

Rapid self-infusion of tap water.

Chaudhary S, Kashani K, Williams AW, El-Zoghby ZM, Albright RC, Qian Q.

Iran J Kidney Dis. 2013 Mar;7(2):156-9.

24.

Cardiac troponin T before and after kidney transplantation: determinants and implications for posttransplant survival.

Keddis MT, El-Zoghby ZM, El Ters M, Rodrigo E, Pellikka PA, Jaffe AS, Cosio FG.

Am J Transplant. 2013 Feb;13(2):406-14. doi: 10.1111/j.1600-6143.2012.04317.x. Epub 2012 Nov 8.

25.

Severe anion gap metabolic acidosis from acetaminophen use secondary to 5-oxoproline (pyroglutamic acid) accumulation.

Zand L, Muriithi A, Nelsen E, Franco PM, Greene EL, Qian Q, El-Zoghby ZM.

Am J Med Sci. 2012 Dec;344(6):501-4. doi: 10.1097/MAJ.0b013e318259bd45.

PMID:
22986610
26.

Urolithiasis and the risk of ESRD.

El-Zoghby ZM, Lieske JC, Foley RN, Bergstralh EJ, Li X, Melton LJ 3rd, Krambeck AE, Rule AD.

Clin J Am Soc Nephrol. 2012 Sep;7(9):1409-15. Epub 2012 Jun 28.

27.

Adenovirus-induced interstitial nephritis following umbilical cord blood transplant for chronic lymphocytic leukemia.

Keddis M, Leung N, Herrmann S, El-Zoghby Z, Sethi S.

Am J Kidney Dis. 2012 Jun;59(6):886-90. doi: 10.1053/j.ajkd.2011.10.056. Epub 2012 Mar 8.

PMID:
22405484
28.

Renal histological lesions and outcome in liver transplant recipients.

Tsapenko M, El-Zoghby ZM, Sethi S.

Clin Transplant. 2012 Jan-Feb;26(1):E48-54. doi: 10.1111/j.1399-0012.2011.01542.x. Epub 2011 Oct 23.

PMID:
22017292
29.

Recurrent idiopathic membranous nephropathy: early diagnosis by protocol biopsies and treatment with anti-CD20 monoclonal antibodies.

El-Zoghby ZM, Grande JP, Fraile MG, Norby SM, Fervenza FC, Cosio FG.

Am J Transplant. 2009 Dec;9(12):2800-7. doi: 10.1111/j.1600-6143.2009.02851.x. Epub 2009 Oct 21.

30.

Patient survival after kidney transplantation: relationship to pretransplant cardiac troponin T levels.

Hickson LJ, El-Zoghby ZM, Lorenz EC, Stegall MD, Jaffe AS, Cosio FG.

Am J Transplant. 2009 Jun;9(6):1354-61. doi: 10.1111/j.1600-6143.2009.02636.x. Epub 2009 May 13. Erratum in: Am J Transplant. 2014 Feb;14(2):497. Hickson, L T J [corrected to Hickson, L J]. Am J Transplant. 2014 Feb;14 (2):497.

31.

Identifying specific causes of kidney allograft loss.

El-Zoghby ZM, Stegall MD, Lager DJ, Kremers WK, Amer H, Gloor JM, Cosio FG.

Am J Transplant. 2009 Mar;9(3):527-35. doi: 10.1111/j.1600-6143.2008.02519.x. Epub 2008 Feb 3.

32.

Surveillance of arteriovenous hemodialysis access: a systematic review and meta-analysis.

Casey ET, Murad MH, Rizvi AZ, Sidawy AN, McGrath MM, Elamin MB, Flynn DN, McCausland FR, Vo DH, El-Zoghby Z, Duncan AA, Tracz MJ, Erwin PJ, Montori VM.

J Vasc Surg. 2008 Nov;48(5 Suppl):48S-54S. doi: 10.1016/j.jvs.2008.08.043. Review.

33.

Autogenous versus prosthetic vascular access for hemodialysis: a systematic review and meta-analysis.

Murad MH, Elamin MB, Sidawy AN, Malaga G, Rizvi AZ, Flynn DN, Casey ET, McCausland FR, McGrath MM, Vo DH, El-Zoghby Z, Duncan AA, Tracz MJ, Erwin PJ, Montori VM.

J Vasc Surg. 2008 Nov;48(5 Suppl):34S-47S. doi: 10.1016/j.jvs.2008.08.044. Review.

34.

Timing of referral for vascular access placement: a systematic review.

Murad MH, Sidawy AN, Elamin MB, Rizvi AZ, Flynn DN, McCausland FR, McGrath MM, Vo DH, El-Zoghby Z, Casey ET, Duncan AA, Tracz MJ, Erwin PJ, Montori VM.

J Vasc Surg. 2008 Nov;48(5 Suppl):31S-3S. doi: 10.1016/j.jvs.2008.08.046. Review.

35.

Survival of patients on the kidney transplant wait list: relationship to cardiac troponin T.

Hickson LJ, Cosio FG, El-Zoghby ZM, Gloor JM, Kremers WK, Stegall MD, Griffin MD, Jaffe AS.

Am J Transplant. 2008 Nov;8(11):2352-9. doi: 10.1111/j.1600-6143.2008.02395.x. Epub 2008 Sep 10.

36.

Obstructive renal failure from malpositioned urinary catheter.

El-Zoghby ZM, Regner KR, Regner DM, Haugen EN.

Kidney Int. 2008 Jun;73(11):1330. doi: 10.1038/sj.ki.5002740. No abstract available.

37.

Intra-tubular amyloidosis.

El-Zoghby Z, Lager D, Gregoire J, Lewin M, Sethi S.

Kidney Int. 2007 Nov;72(10):1282-8. Epub 2007 Jul 4. No abstract available.

Supplemental Content

Loading ...
Support Center